Patents/Assignees

Raqualia Pharma Inc.

4 patents in portfolio

US12552776utility2026
Crystalline Forms
0 cites
US12421191utility2025
3-hydroxyoxindole Derivatives as CRHR2 Antagonist
0 cites
US12110287utility2024
Heterocyclic Derivatives as Nav1.7 and Nav1.8 Blockers
0 cites
US11802120utility2023
Fused Cyclic Urea Derivatives as CRHR2 Antagonist
0 cites